Home > Healthcare > Pharmaceuticals > Finished Drug Form > Omega-3 Prescription Drugs Market

Omega-3 Prescription Drugs Market Share

Report ID: GMI10789
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Omega 3 Prescription Drugs Market Share

The omega-3 prescription drugs sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. Key to market strategy is the consistent launch of innovative products, utilizing a range of technologies. Major industry leaders wield significant influence, spearheading progress with hefty investments in R&D. Furthermore, strategic partnerships and M&A activities play a crucial role in bolstering market standing and broadening global reach, especially in the face of changing regulations.

Omega-3 Prescription Drugs Market Companies

Some of the eminent market participants operating in the omega-3 prescription drugs industry include:

AstraZeneca plc
Amarin Corporation plc
Camber Pharmaceuticals, Inc.
Dr. Reddy’s Laboratories Ltd.
GSK plc
Grupo Ferrer Internacional, S.A.
Hikma Pharmaceuticals PLC
Natco Pharma Limited
Pfizer Inc.
Viatris Inc.
Zydus Lifesciences Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Omega-3 prescription drugs industry size was worth USD 1.4 billion in 2023 and will grow at an 8.2% CAGR between 2024 and 2032 due to the rising prevalence of cardiovascular diseases, and growing consumer preference for natural and preventive healthcare solutions.

The cardiovascular diseases segment accumulated USD 643.9 million in 2023, driven by the widespread prevalence of heart-related conditions globally.

U.S. omega-3 prescription drugs industry will reach USD 1.1 billion by 2032, attributed to its high prevalence of cardiovascular diseases, robust healthcare infrastructure, and strong consumer awareness of omega-3 benefits.

Prominent players operating in the omega-3 prescription drugs industry are AstraZeneca plc, Amarin Corporation plc, Camber Pharmaceuticals, Inc., Dr. Reddy